Literature DB >> 26335850

STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.

Cyril X George1, Charles E Samuel2.   

Abstract

Expression of adenosine deaminase acting on RNA1 (ADAR1) is driven by alternative promoters. Promoter PA, activated by interferon (IFN), produces transcripts that encode the inducible p150 ADAR1 protein, whereas PB specifies the constitutively expressed p110 protein. We show using Stat1(-/-), Stat2(-/-) and IRF9(-/-) MEFs that induction of ADAR1 p150 occurs by STAT2- and IRF9-dependent signaling that is enhanced by, but not obligatorily dependent upon, STAT1. Chromatin immunoprecipitation analysis demonstrated STAT2 at the PA promoter in IFN-treated Stat1(-/-) cells, whereas IFN-treated wild-type cells showed both STAT1 and STAT2 bound at PA. By contrast, with human 2fTGH cells and mutants U3A or U6A, ADAR1 induction by IFN was dependent upon both STAT1 and STAT2. These results suggest that transcriptional activation of Adar1 by IFN occurs in the absence of STAT1 by a non-canonical STAT2-dependent pathway in mouse but not human cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosine deaminase acting on RNA (ADAR); Innate immunity; Interferon (IFN); Signal transducers and activators of transcription (STAT)

Mesh:

Substances:

Year:  2015        PMID: 26335850      PMCID: PMC4619148          DOI: 10.1016/j.virol.2015.08.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  Immune response in Stat2 knockout mice.

Authors:  C Park; S Li; E Cha; C Schindler
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

Review 2.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.

Authors:  Thomas A Kraus; Joe F Lau; Jean-Patrick Parisien; Curt M Horvath
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

4.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 5.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 6.  The JAK-STAT pathway at twenty.

Authors:  George R Stark; James E Darnell
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

Review 7.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication.

Authors:  Jean-Patrick Parisien; Joe F Lau; Curt M Horvath
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

10.  The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins.

Authors:  Simone Visosky Ward; Charles E Samuel
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

View more
  7 in total

Review 1.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

Review 2.  When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.

Authors:  Yumeng Wang; Han Liang
Journal:  Bioessays       Date:  2017-12-27       Impact factor: 4.345

3.  ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.

Authors:  Maria Anna Zipeto; Angela C Court; Anil Sadarangani; Nathaniel P Delos Santos; Larisa Balaian; Hye-Jung Chun; Gabriel Pineda; Sheldon R Morris; Cayla N Mason; Ifat Geron; Christian Barrett; Daniel J Goff; Russell Wall; Maurizio Pellecchia; Mark Minden; Kelly A Frazer; Marco A Marra; Leslie A Crews; Qingfei Jiang; Catriona H M Jamieson
Journal:  Cell Stem Cell       Date:  2016-06-09       Impact factor: 24.633

4.  Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.

Authors:  Cyril X George; Gokul Ramaswami; Jin Billy Li; Charles E Samuel
Journal:  J Biol Chem       Date:  2016-01-27       Impact factor: 5.157

5.  Inhibition of PKR protects against H2O2-induced injury on neonatal cardiac myocytes by attenuating apoptosis and inflammation.

Authors:  Yongyi Wang; Min Men; Bo Xie; Jianggui Shan; Chengxi Wang; Jidong Liu; Hui Zheng; Wengang Yang; Song Xue; Changfa Guo
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

6.  STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.

Authors:  Shota Yamauchi; Kenji Takeuchi; Kazuyasu Chihara; Chisato Honjoh; Yuji Kato; Hatsumi Yoshiki; Hak Hotta; Kiyonao Sada
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

7.  ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance.

Authors:  Li Jiang; Yajing Hao; Changwei Shao; Qiulian Wu; Briana C Prager; Ryan C Gimple; Gabriele Sulli; Leo Jy Kim; Guoxin Zhang; Zhixin Qiu; Zhe Zhu; Xiang-Dong Fu; Jeremy N Rich
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 19.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.